Goldman Sachs’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$145M Sell
277,371
-28,476
-9% -$13.6M 0.02% 837
2025
Q4
$178M Sell
305,847
-80,253
-21% -$41M 0.03% 684
2025
Q3
$177M Buy
386,100
+196,260
+103% +$73.2M 0.03% 664
2025
Q2
$57.5M Buy
189,840
+201
+0.1% +$59.9K 0.01% 1241
2025
Q1
$62.8M Sell
189,639
-41,811
-18% -$13.7M 0.01% 1071
2024
Q4
$71.4M Sell
231,450
-8,330
-3% -$2.34M 0.01% 1018
2024
Q3
$50.9M Buy
239,780
+68,329
+40% +$17.5M 0.01% 1227
2024
Q2
$48M Buy
171,451
+79,662
+87% +$19M 0.01% 1184
2024
Q1
$24.5M Buy
91,789
+6,686
+8% +$1.58M 0.01% 1670
2023
Q4
$19.7M Buy
85,103
+8,691
+11% +$1.52M ﹤0.01% 1901
2023
Q3
$11.2M Buy
76,412
+6,103
+9% +$1.15M ﹤0.01% 2299
2023
Q2
$16.2M Sell
70,309
-72,682
-51% -$19.7M ﹤0.01% 2025
2023
Q1
$34.6M Sell
142,991
-20,800
-13% -$5.67M 0.01% 1336
2022
Q4
$47.5M Sell
163,791
-16,611
-9% -$1.62M 0.01% 1213
2022
Q3
$11.7M Buy
180,402
+127,776
+243% +$8.88M ﹤0.01% 2361
2022
Q2
$3.77M Buy
52,626
+4,038
+8% +$297K ﹤0.01% 3443
2022
Q1
$4.77M Sell
48,588
-56,891
-54% -$4.8M ﹤0.01% 3400
2021
Q4
$8.94M Sell
105,479
-49,691
-32% -$4.08M ﹤0.01% 2877
2021
Q3
$12.4M Buy
155,170
+45,883
+42% +$3.96M ﹤0.01% 2505
2021
Q2
$10.6M Buy
109,287
+20,441
+23% +$2.42M ﹤0.01% 2632
2021
Q1
$10.4M Buy
88,846
+20,738
+30% +$2.42M ﹤0.01% 2532
2020
Q4
$7.57M Sell
68,108
-46,794
-41% -$5.72M ﹤0.01% 2678
2020
Q3
$13.6M Buy
114,902
+10,305
+10% +$1.12M ﹤0.01% 2058
2020
Q2
$11.8M Sell
104,597
-97,270
-48% -$9.57M ﹤0.01% 2136
2020
Q1
$13.5M Buy
201,867
+37,066
+22% +$3.09M 0.01% 1827
2019
Q4
$15M Buy
164,801
+60,567
+58% +$5.87M ﹤0.01% 2098
2019
Q3
$8.99M Sell
104,234
-937
-0.9% -$87.9K ﹤0.01% 2400
2019
Q2
$11M Sell
105,171
-16,917
-14% -$1.81M ﹤0.01% 2289
2019
Q1
$15.3M Buy
122,088
+34,378
+39% +$4.27M 0.01% 2094
2018
Q4
$9.89M Buy
87,710
+16,845
+24% +$2.61M ﹤0.01% 2352
2018
Q3
$15.2M Buy
70,865
+31,623
+81% +$7.94M ﹤0.01% 2128
2018
Q2
$11M Buy
39,242
+36,536
+1,350% +$6.42M ﹤0.01% 2340
2018
Q1
$316K Sell
2,706
-2,287
-46% -$282K ﹤0.01% 4754
2017
Q4
$458K Buy
+4,993
New +$285K ﹤0.01% 4892
2017
Q2
Sell
-20,836
Closed -$321K 6876
2017
Q1
$321K Buy
+20,836
New +$328K ﹤0.01% 5413
2016
Q4
Sell
-12,043
Closed -$153K 7000
2016
Q3
$153K Buy
12,043
+4,472
+59% +$43.3K ﹤0.01% 5995
2016
Q2
$69K Buy
7,571
+4,326
+133% +$51.9K ﹤0.01% 6297
2016
Q1
$27K Sell
3,245
-34,034
-91% -$284K ﹤0.01% 6655
2015
Q4
$459K Buy
37,279
+23,083
+163% +$633K ﹤0.01% 4997
2015
Q3
$865K Buy
14,196
+4,946
+53% +$357K ﹤0.01% 4612
2015
Q2
$722K Sell
9,250
-1,861
-17% -$156K ﹤0.01% 4850
2015
Q1
$754K Sell
11,111
-415
-4% -$35.6K ﹤0.01% 4740
2014
Q4
$1.07M Sell
11,526
-11,052
-49% -$1.14M ﹤0.01% 4493
2014
Q3
$2.38M Buy
22,578
+837
+4% +$116K ﹤0.01% 3766
2014
Q2
$3.11M Buy
21,741
+846
+4% +$124K ﹤0.01% 3547
2014
Q1
$3.15M Buy
20,895
+16,902
+423% +$3.33M ﹤0.01% 3546
2013
Q4
$732K Buy
3,993
+3,102
+348% +$568K ﹤0.01% 5009
2013
Q3
$197K Sell
891
-9,206
-91% -$1.96M ﹤0.01% 5878
2013
Q2
$1.76M Buy
+10,097
New +$2.63M ﹤0.01% 3848

Other funds holding MDGL